Defunct Company
Total Trials
3
As Lead Sponsor
0
As Collaborator
Total Enrollment
1,200
NCT04239703
Trifecta-Kidney cfDNA-MMDx Study
Phase: N/A
Role: Collaborator
Start: Dec 1, 2019
Completion: Dec 31, 2026
NCT04707872
Trifecta-Heart cfDNA-MMDx Study
Start: Jun 1, 2021
Completion: Jul 31, 2027
NCT05837663
Trifecta-Lung cfDNA-MMDx Study
Start: Nov 1, 2023
Completion: Dec 31, 2027